Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
CAS Medical Systems said that it sold its 740 Select line of vital sign monitoring products to Zoe Medical for an unspecified amount.
Branford, Conn.-based CasMed said it made the move so that it can focus solely on its Fore-Sight cerebral oximetry business. The 740 Select operation put up $3.7 million in sales last year and $1.3 million during the 1st 6 months of 2015, the company said. Read more
Glaukos said that it agreed to settle a patent infringement lawsuit brought by eye stent rival Transcend Medical.
The agreement, in which both sides agree not to sue for patent infringement, calls for Transcend to pay a 1% royalty on sales of its Cy-Pass micro-stent until April 2022, with the total amount capped at $6 million, Glaukos said. Read more
A federal appeals court handed a win to Medtronic that could wind up helping Twin Cities rival St. Jude Medical, in a pair of decisions concerning patents covering remote patient monitoring technology.
In the Medtronic case, the U.S. Court of Appeals for the Federal Circuit ruled that a lower court judge wrongly interpreted the patent, overturning validity decision in favor of Atlas IP and remanding the case back to the U.S. District Court for Southern Florida. The Federal Circuit also upheld Judge Cecilia Altonaga’s judgment of non-infringement in favor of Medtronic. Read more